WOBURN, Mass.–(BUSINESS WIRE)– #Oralmedicines–Orogen Therapeutics announces selection of two development candidates for immune diseases.
WOBURN, Mass.–(BUSINESS WIRE)– #Oralmedicines–Orogen Therapeutics announces selection of two development candidates for immune diseases.